RELATIVE EFFICACY AND SAFETY OF INTRAVENOUS DRUGS FOR TERMINATION OF SUSTAINED VENTRICULAR-TACHYCARDIA

被引:42
作者
GRIFFITH, MJ [1 ]
LINKER, NJ [1 ]
GARRATT, CJ [1 ]
WARD, DE [1 ]
CAMM, AJ [1 ]
机构
[1] ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND
关键词
D O I
10.1016/0140-6736(90)92158-E
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relative safety and efficacy of intravenous administration of adenosine, lignocaine, disopyramide, flecainide, and sotalol for termination of stable, induced ventricular tachycardia was assessed in serial trials. Ventricular tachycardia was terminated by pacing if it persisted 10-15 min after the end of drug administration. 24 patients with recurrent ventricular tachycardia were studied. Ventricular tachycardia was terminated by a drug in 35 of 105 trials. In 6 patients no drug terminated the arrhythmia. Adenosine did not terminate tachycardia or have any serious adverse effect in any patient; both flecainide and disopyramide were significantly more effective than lignocaine, but flecainide had significantly more severe adverse effects than lignocaine. Lignocaine was the safest drug and should continue to be used as first-line drug therapy for stable ventricular tachycardia. Disopyramide should be considered as second-line treatment. DC cardioversion is necessary for unstable ventricular tachycardia, and its availability must be ensured before attempted pharmacological intervention. © 1990.
引用
收藏
页码:670 / 673
页数:4
相关论文
共 26 条
[1]  
ANDERSON JL, 1984, AM J CARDIOL, V53, pB79, DOI 10.1016/0002-9149(84)90507-1
[2]   SIGNIFICANCE OF VENTRICULAR ARRHYTHMIAS INITIATED BY PROGRAMMED VENTRICULAR STIMULATION - THE IMPORTANCE OF THE TYPE OF VENTRICULAR ARRHYTHMIA INDUCED AND THE NUMBER OF PREMATURE STIMULI REQUIRED [J].
BRUGADA, P ;
GREEN, M ;
ABDOLLAH, H ;
WELLENS, HJJ .
CIRCULATION, 1984, 69 (01) :87-92
[3]   FLECAINIDE - LONG-TERM TREATMENT USING A REDUCED DOSING SCHEDULE [J].
FLOWERS, D ;
OGALLAGHER, D ;
TORRES, V ;
MIURA, D ;
SOMBERG, JC .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (01) :79-83
[4]   ANTIARRHYTHMIC DRUGS .7. LIDOCAINE AS AN ANTIARRHYTHMIC AGENT [J].
FRIEDEN, J .
AMERICAN HEART JOURNAL, 1965, 70 (05) :713-&
[5]   COMPARISON OF ADENOSINE AND VERAPAMIL FOR TERMINATION OF PAROXYSMAL JUNCTIONAL TACHYCARDIA [J].
GARRATT, C ;
LINKER, N ;
GRIFFITH, M ;
WARD, D ;
CAMM, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (19) :1310-1316
[6]   DISOPYRAMIDE - EFFECTIVE TREATMENT FOR LIGNOCAINE RESISTANT VENTRICULAR DYSRHYTHMIAS [J].
GREEN, AGH .
SCOTTISH MEDICAL JOURNAL, 1979, 24 (01) :21-24
[7]   ANTIARRHYTHMIC PROPERTIES OF LIDOCAINE AND PROCAINE AMIDE - CLINICAL PHYSIOLOGIC STUDIES OF THEIR CARDIOVASCULAR EFFECTS IN MAN [J].
HARRISON, DC ;
SPROUSE, JH ;
MORROW, AG .
CIRCULATION, 1963, 28 (04) :486-&
[8]   ANTIARRHYTHMIC AGENTS - MODULATED RECEPTOR APPLICATIONS [J].
HONDEGHEM, LM .
CIRCULATION, 1987, 75 (03) :514-520
[9]  
HULTING J, 1976, J INT MED RES, V4, P90
[10]   DISOPYRAMIDE - EVALUATION OF ELECTROPHYSIOLOGIC EFFECTS AND CLINICAL EFFICACY IN PATIENTS WITH SUSTAINED VENTRICULAR-TACHYCARDIA OR VENTRICULAR-FIBRILLATION [J].
LERMAN, BB ;
WAXMAN, HL ;
BUXTON, AE ;
JOSEPHSON, ME .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (05) :759-764